July 2025
1. WU R, Li X, Wu Y, Zhao Z, et al
   External validation of population pharmacokinetic models of oxcarbazepine active metabolite in Chinese children with epilepsy.
   Eur J Clin Pharmacol. 2025 Jul 24. doi: 10.1007/s00228-025-03875.
   

   >> Share

   
   
2. CHEN J, Wang J, Li K, Wu Y, et al
   Dosing prediction of valproic acid in pediatric patients with epilepsy: population pharmacokinetic model or machine learning model?
   Eur J Clin Pharmacol. 2025 Jul 5. doi: 10.1007/s00228-025-03874.
   

   >> Share

   
   February 2025
3. WANG S, Sun H, Wang Z, Sun C, et al
   Adjunctive treatment for pediatric focal epilepsy: a systematic review.
   Eur J Clin Pharmacol. 2025 Feb 13. doi: 10.1007/s00228-025-03807.
   

   >> Share

   
   November 2024
4. PRETORIUS E, van Zyl P, Joubert G
   Therapeutic drug monitoring for valproate: deriving a novel formula for calculation of free concentration.
   Eur J Clin Pharmacol. 2024;80:1751-1759.
   

   >> Share

   
   August 2024
5. WU R, Li K, Zhao Z, Mei S, et al
   Fixed parameters in the population pharmacokinetic modeling of valproic acid might not be suitable: external validation in Chinese adults with epilepsy or after neurosurgery.
   Eur J Clin Pharmacol. 2024 Aug 29. doi: 10.1007/s00228-024-03746.
   

   >> Share

   
   October 2023
6. CHEN J, Huang L, Zeng L, Jiang Z, et al
   The reference range of lamotrigine in the treatment of epilepsy in children: a systematic review.
   Eur J Clin Pharmacol. 2023 Oct 31. doi: 10.1007/s00228-023-03562.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share